|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Allowance (recovery) of CECL - trade receivable, net | |||||
| (Gain) loss on foreign currency transactions | |||||
| Gain on conversion of functional currency from US $ to GBP - MD Local | |||||
| Loss on sale of assets | |||||
| Gain on valuation of warrants | |||||
| Gain on deconsolidation | |||||
| Share-based compensation | |||||
| Employees | |||||
| Executive officers | |||||
| Total share-based compensation | |||||
| Non cash interest expense | |||||
| Changes in deferred tax assets | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease in accounts receivables | |||||
| (Increase) decrease in other receivables | |||||
| (Increase) decrease in prepaid expense | |||||
| (Decrease) increase in accounts payable and accrued expenses | |||||
| (Decrease) increase in VAT and other tax payable | |||||
| (Decrease) increase in related party payable | |||||
| (Decrease) increase in deferred income | |||||
| Net Cash Used in Operating Activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchase of fixtures,office equipment and improvements | |||||
| Proceeds from disposal of assets | |||||
| Loan repayment received | |||||
| Cash disposed of from deconsolidation of VIE | |||||
| Net Cash Used in Investing Activities | |||||
| Cash Flows from Financing Activities: | |||||
| Repayment of short term loans | |||||
| Proceeds from private placement | |||||
| Costs of private placement | |||||
| Proceeds from exercise series warrants A and B | |||||
| Net Cash Provided by (Used in) Financing Activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash - beginning of the period | |||||
| Cash, cash equivalents, and restricted cash - end of the period | |||||
| Cash and cash equivalents | |||||
| Restricted foreign currency | |||||
| Total cash, cash equivalents, and restricted cash | |||||
| Non-cash investing and financing activities | |||||
| Share-based compensation applied to construction in progress | |||||
| Reclassification of warrant liability to equity upon exercise of warrants | |||||
Loading...